Alnylam Pharmaceuticals
ALNY
#570
Rank
NZ$73.62 B
Marketcap
NZ$551.77
Share price
0.26%
Change (1 day)
35.44%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company